Your browser doesn't support javascript.
loading
Treatment with PCSK9 inhibitors induces a more anti-atherogenic HDL lipid profile in patients at high cardiovascular risk.
Ingueneau, Cécile; Hollstein, Tim; Grenkowitz, Thomas; Ruidavets, Jean-Bernard; Kassner, Ursula; Duparc, Thibaut; Combes, Guillaume; Perret, Bertrand; Genoux, Annelise; Schumann, Friederike; Bobbert, Thomas; Steinhagen-Thiessen, Elisabeth; Martinez, Laurent O.
Affiliation
  • Ingueneau C; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France; Service de Biochimie, Pôle de biologie, Hôpital de Purpan, CHU de Toulouse,
  • Hollstein T; Department of Endocrinology, Division of Lipid Disorders, Charité Universitätsmedizin Berlin, Berlin, Germany; Division of Endocrinology, Diabetology and Clinical Nutrition, Department of Internal Medicine 1, University of Kiel, Arnold Heller Straße 3, Kiel 24105, Germany. Electronic address: tim.ho
  • Grenkowitz T; Department of Endocrinology, Division of Lipid Disorders, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Ruidavets JB; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1027, Toulouse, France.
  • Kassner U; Department of Endocrinology, Division of Lipid Disorders, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Duparc T; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France.
  • Combes G; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France.
  • Perret B; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France; Service de Biochimie, Pôle de biologie, Hôpital de Purpan, CHU de Toulouse,
  • Genoux A; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France; Service de Biochimie, Pôle de biologie, Hôpital de Purpan, CHU de Toulouse,
  • Schumann F; Department of Endocrinology, Division of Lipid Disorders, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Bobbert T; Department of Endocrinology, Division of Lipid Disorders, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Steinhagen-Thiessen E; Department of Endocrinology, Division of Lipid Disorders, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Martinez LO; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France.
Vascul Pharmacol ; 135: 106804, 2020 12.
Article in En | MEDLINE | ID: mdl-32987194
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serine Proteinase Inhibitors / Atherosclerosis / Dyslipidemias / PCSK9 Inhibitors / Cholesterol, HDL / Anticholesteremic Agents Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Vascul Pharmacol Journal subject: ANGIOLOGIA / FARMACOLOGIA Year: 2020 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serine Proteinase Inhibitors / Atherosclerosis / Dyslipidemias / PCSK9 Inhibitors / Cholesterol, HDL / Anticholesteremic Agents Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Vascul Pharmacol Journal subject: ANGIOLOGIA / FARMACOLOGIA Year: 2020 Document type: Article Country of publication: United States